NYSE:J
NYSE:JProfessional Services

Is Jacobs Solutions (J) Fairly Priced After Recent Steady Multi Year Share Gains

Wondering if Jacobs Solutions at around US$141.50 is giving you fair value for the risk you take, or if the price is leaving too much on the table. The stock has seen returns of 2.2% over the last 7 days, 5.6% over 30 days, 4.5% year to date, 4.3% over 1 year, 48.1% over 3 years and 60.4% over 5 years, which naturally raises questions about how much of that performance is already reflected in the current share price. Recent news around Jacobs Solutions has focused on its role as a large US...
NYSE:EFX
NYSE:EFXProfessional Services

Assessing Equifax (EFX) Valuation After Mar Vista Exit And Credit Scoring Uncertainty

Why Mar Vista walked away from Equifax Equifax (EFX) is back under the spotlight after Mar Vista Investment Partners fully exited its position, citing pressure from FICO’s new approach to mortgage credit scoring and a slower housing market recovery. For you as an investor, this move highlights two key questions: how much of Equifax’s credit scoring economics could be at risk over time, and whether the current stock price fairly reflects those changing industry terms. See our latest analysis...
NYSE:DCI
NYSE:DCIMachinery

A Look At Donaldson Company (DCI) Valuation After Jefferies Upgrade And Higher Earnings Guidance

Jefferies’ upgrade of Donaldson Company (DCI), following improved mining and non-residential construction trends and higher full-year margin and earnings guidance, has put fresh attention on how this filtration specialist’s multi-segment momentum could influence investor expectations. See our latest analysis for Donaldson Company. The Jefferies upgrade and higher guidance come on top of a solid run in the shares, with a 90 day share price return of 21.7% and a 1 year total shareholder return...
NYSE:HSY
NYSE:HSYFood

A Look At Hershey (HSY) Valuation After New Shaq Collaboration And Valentine’s Candy Launches

Hershey (HSY) has been back in the spotlight after rolling out Shaq A Licious SLAMS with Shaquille O'Neal and refreshing its Valentine’s lineup, while also stepping up marketing behind its core chocolate brand. See our latest analysis for Hershey. Those new candy launches and the bigger marketing push have arrived alongside a pickup in investor interest, with a 7-day share price return of 8.83% and a 1-year total shareholder return of 34.83% suggesting momentum has recently improved after a...
NYSE:VLO
NYSE:VLOOil and Gas

Will Middle East Tensions and Higher Crude Benchmarks Change Valero Energy's (VLO) Risk Narrative?

Earlier this week, Valero Energy participated in a broad rally among oil and gas companies as WTI crude reached a multi‑month high amid rising geopolitical tensions involving Iran, lifting sentiment across the energy sector. This move underscores how shifts in geopolitical risk and crude benchmarks can quickly influence expectations for refining economics and earnings potential at Valero. We’ll now examine how heightened Middle East tensions and stronger crude prices may influence Valero’s...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

The Bull Case For Golar LNG (GLNG) Could Change Following Long-Term Argentina FLNG Charter Progress - Learn Why

In the past few months, Goldman Sachs began covering Golar LNG Limited with a positive view, while Golar confirmed that all Conditions Precedent for its 20‑year MKII FLNG charter with Southern Energy in Argentina had been satisfied, securing a long-term commercial arrangement. These developments, occurring against the backdrop of Argentina’s recent election of Javier Milei, meaningfully reduce policy uncertainty around the project and sharpen focus on Golar’s exposure to LNG-linked commodity...
NasdaqGS:LULU
NasdaqGS:LULULuxury

Is It Time To Reassess Lululemon Athletica (LULU) After A 45% One Year Share Price Slide

If you are wondering whether lululemon athletica's current share price still reflects its long term potential, you are not alone. This article is built to help you size up what you are really paying for today. The stock last closed at US$205.01, with returns of a 3.4% decline over 7 days, a 0.8% decline over 30 days, a 2.8% decline year to date and a 44.7% decline over 1 year, while the 3 and 5 year returns stand at a 33.4% decline and a 41.3% decline. Recent coverage has focused on...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Beam Therapeutics (BEAM) Is Up 14.5% After FDA-Aligned Pathway And Cash Runway Update – Has The Bull Case Changed?

In recent updates, Beam Therapeutics reported past progress with the FDA on a potential accelerated approval pathway for its BEAM-302 program in alpha-1 antitrypsin deficiency and outlined plans to file a biologics license application for its sickle cell therapy, risto-cel, as early as the end of 2026, supported by inclusion in expedited review initiatives and an operating cash runway into 2029. An important insight is that Beam’s combination of regulatory alignment, CMC support via an FDA...
NYSE:NEM
NYSE:NEMMetals and Mining

Newmont (NEM) Is Up 6.8% After Record Gold Prices and Tier 1 Portfolio Gains - Has The Bull Case Changed?

In recent months, Newmont has benefited from record-high gold prices, strong profitability metrics, and the ramp-up of projects such as Ahafo North, while preparing to report its full-year 2025 results in February 2026. Analysts and quantitative models have turned increasingly positive on Newmont’s fundamentals, citing its Tier 1 asset focus, global portfolio quality, and disciplined capital allocation, including ongoing divestitures of non-core assets. We’ll now examine how Newmont’s...
NasdaqGS:BBSI
NasdaqGS:BBSIProfessional Services

Assessing Barrett Business Services (BBSI) Valuation After New Employee File Cabinet HR Tech Launch

What the new Employee File Cabinet launch means for BBSI shareholders Barrett Business Services (BBSI) has rolled out its Employee File Cabinet HRIS module within the BBSI Client Portal, built with Box, giving clients a secure, centralized hub for key HR documents. The launch highlights BBSI’s ongoing push to consolidate HR workflows into a single portal experience. The company points to potential benefits around compliance, time savings, and employee access to their own documents. See our...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

Monolithic Power Systems (MPWR) Is Up 5.3% After Wells Fargo Upgrade on Sector Outlook Shift – What's Changed

Recently, Wells Fargo upgraded Monolithic Power Systems to an Overweight rating, citing an improving outlook for the semiconductor sector and potential customer inventory replenishment as key supports for the company’s power-management chip business. The upgrade also highlighted that upcoming results will be measured against a softer period last year, which could make any operational progress appear more pronounced relative to prior performance. Next, we’ll examine how Wells Fargo’s more...
NasdaqGS:RNW
NasdaqGS:RNWRenewable Energy

A Look At ReNew Energy Global (NasdaqGS:RNW) Valuation After Recent Share Price Swings

ReNew Energy Global (RNW) has drawn attention after recent share price moves left the stock with mixed return patterns, including a gain over the past month but declines across the past 3 months and year. See our latest analysis for ReNew Energy Global. The recent 4.05% 1 month share price return contrasts with a 29.60% 3 month share price decline and a 19.76% 1 year total shareholder return loss, suggesting momentum has picked up in the short term after a weaker longer run. If ReNew’s swings...
NYSE:NRGV
NYSE:NRGVElectrical

Why Energy Vault (NRGV) Is Up 11.5% After Launching Its First ERCOT Asset Vault Project

Energy Vault Holdings, Inc. previously filed a shelf registration for US$180.55 million of common stock, while also beginning construction on the 150 MW/300 MWh SOSA Energy Center battery storage project in Madison County, Texas under its Asset Vault "Own & Operate" platform. This combination of fresh financing capacity and the company’s first Asset Vault project in the ERCOT North market highlights a shift toward owned infrastructure backed by recurring revenues and supported by a US$300...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

How Investors Are Reacting To BrightSpring Health Services (BTSG) Analyst Focus On Home-Based Care

Recently, BrightSpring Health Services attracted heightened investor attention as analysts highlighted its position in home and community-based healthcare, particularly serving Medicare, Medicaid, and insured populations through its Pharmacy Solutions and Provider Services segments. An interesting angle is how this analyst enthusiasm centers on BrightSpring’s growth prospects in integrated home-based care, a part of healthcare that is gaining importance as care increasingly shifts away from...
NasdaqGS:DRH
NasdaqGS:DRHHotel and Resort REITs

A Look At DiamondRock Hospitality (DRH) Valuation After Upgrade Dividend Hike And Planned Nasdaq Move

Why DiamondRock Hospitality Stock Is Back on Investor Radars DiamondRock Hospitality (DRH) is drawing fresh attention after Deutsche Bank upgraded the stock, along with a 12.5% dividend increase for 2025 and a planned move to Nasdaq's Global Select Market. See our latest analysis for DiamondRock Hospitality. The stock has been quietly gathering momentum, with a 20.31% 90 day share price return and a 1 year total shareholder return of 8.07%. This suggests sentiment has improved alongside the...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

A Look At Sarepta Therapeutics (SRPT) Valuation After Elevidys Safety Setbacks And 2025 Revenue Miss

Why Sarepta’s recent safety and revenue setbacks matter for SRPT Sarepta Therapeutics (SRPT) has been under pressure after missing 2025 net product revenue forecasts and facing serious safety and regulatory issues tied to its Elevidys gene therapy, including FDA warnings and reported patient deaths. See our latest analysis for Sarepta Therapeutics. Those safety and revenue setbacks have fed into weak momentum, with a 1-day share price return of 6.54% and a 7-day return of 7.95%, while the...
NYSE:MA
NYSE:MADiversified Financial

Is Mastercard (MA) Still Sensibly Priced After Recent Share Price Weakness And Fee Debates

If you are wondering whether Mastercard's share price still makes sense at current levels, the key question is how its underlying value compares with what the market is paying. The stock recently closed at US$542.65, with returns of a 6.5% decline over 7 days, a 4.1% decline over 30 days, a 3.6% decline year to date, 4.3% over 1 year, 50.1% over 3 years, and 67.0% over 5 years. This gives you a mix of shorter term weakness and longer term strength to consider. Recent headlines around...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Is Illumina (ILMN) Pricing Reflect Its Worth After Regulatory Scrutiny And Mixed Long Term Returns

If you are wondering whether Illumina's current share price reflects its true worth, this article walks through the key numbers that matter before you make up your mind. Illumina's stock recently closed at US$145.30, with returns of 10.4% over 30 days, 8.2% year to date and 5.8% over 1 year, but declines of 23.9% over 3 years and 63.1% over 5 years, highlighting how mixed the journey has been for long term holders. Recent news around Illumina has focused on ongoing questions about its...
NYSE:PFE
NYSE:PFEPharmaceuticals

Has The Market Overlooked Pfizer (PFE) After The Post‑Pandemic Reset?

If you are wondering whether Pfizer's current share price fairly reflects its fundamentals, you are not alone. This article is designed to help you weigh that up clearly. Pfizer shares last closed at US$25.89, with returns of 2.4% over the past 7 days, 1.4% over 30 days, 2.8% year to date, 4.8% over 1 year, a 31.5% decline over 3 years, and a 9.4% decline over 5 years. This provides important context before looking at any valuation numbers. Recent headlines around Pfizer have focused on the...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Is Acadia’s 2028 Sales Target and DAYBUE STIX Launch Altering The Investment Case For ACADIA (ACAD)?

In early January 2026, Acadia Pharmaceuticals used the J.P. Morgan Healthcare Conference and Biotech Showcase to outline its long-range plans, including projected combined net sales of about US$1.70 billion by 2028 from NUPLAZID and DAYBUE and the staged U.S. launch of DAYBUE STIX for Rett syndrome starting in Q1 2026. The company also highlighted an upcoming Phase 2 readout for remlifanserin in Alzheimer’s disease psychosis expected between August and October 2026, underlining management’s...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

What Agilysys (AGYS)'s YMCA of the Rockies Platform Win Means For Shareholders

Agilysys, Inc. recently announced that YMCA of the Rockies has adopted 15 of its hospitality software solutions to modernize lodging, dining, activities and guest services across its two large Colorado campuses, Estes Park Center and Snow Mountain Ranch. This wide-ranging, integrated deployment at one of the largest family and group resorts in the United States underscores Agilysys’s ability to support complex, high-capacity hospitality operations with a single software ecosystem. We’ll now...
NasdaqGS:AMKR
NasdaqGS:AMKRSemiconductor

Assessing Amkor Technology (AMKR) Valuation After Strong Multi‑Period Share Price Gains

With no single event driving headlines today, Amkor Technology (AMKR) is drawing attention as investors weigh its recent share performance, current valuation signals and the scale of its outsourced semiconductor packaging and test operations. See our latest analysis for Amkor Technology. Recent trading has been choppy, with a 1-day share price return of 1.09% and a 7-day share price return showing a 3.53% decline. This comes alongside a much stronger 30-day and 90-day share price return of...
NYSE:RF
NYSE:RFBanks

Should Regions Financial’s Planned CFO Succession Shape How RF Investors View Its Risk And Capital Strategy?

Regions Financial recently announced that longtime Chief Financial Officer and Senior Executive Vice President David J. Turner, Jr. will retire on March 31, 2026, with current Controller and head of Corporate Finance Anil D. Chadha set to assume the CFO and Senior Executive Vice President roles. This carefully planned internal succession, featuring a finance leader deeply involved in Regions’ reporting, capital, and risk analytics functions, is important because it signals continuity in how...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

A Look At Sterling Infrastructure (STRL) Valuation After Strong Multi Year Shareholder Returns

Why Sterling Infrastructure Is On Investors’ Radar Sterling Infrastructure (STRL) has been drawing attention after strong multi year total returns, with 1 year and 3 year figures well above its shorter term moves over the past month and past 3 months. See our latest analysis for Sterling Infrastructure. The recent 1 day share price return of 5.34% and 7 day share price return of 13.00% at a share price of $336.31 come after a softer 90 day share price return of a 5.42% decline. However, the...